The preparation method of solifenacin intermediate

A solifenacin and intermediate technology, applied in the field of drug synthesis, can solve problems such as heavy metal residues and stricter requirements for heavy metal impurities, and achieve high recovery, easy-to-obtain reagents, and environmental friendliness

Active Publication Date: 2021-07-20
ENANTIOTECH CORP +1
View PDF11 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the (R)-(-)-3-quinine alcohol synthesized by the above-mentioned method has the risk of heavy metal residue, and (R)-(-)-3-quinine alcohol is the last step in the preparation of solifenacin bulk drug Raw materials, the quality standards, especially the heavy metal impurities, are becoming stricter

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • The preparation method of solifenacin intermediate
  • The preparation method of solifenacin intermediate
  • The preparation method of solifenacin intermediate

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0038] The invention provides a kind of preparation method of solifenacin intermediate, described preparation method comprises the following steps:

[0039] Dissolve 3-quinuclidone hydrochloride in a solvent to obtain 3-quinuclidone hydrochloride solution;

[0040] Adding a basic compound and a catalyst to the 3-quinuclidone hydrochloride solution, feeding hydrogen, stirring and reacting to obtain a reactant;

[0041] The catalyst in the reactant is recovered by filtration, and the obtained filtrate is concentrated under reduced pressure and then recrystallized;

[0042] Described catalyst has the structure shown in formula I:

[0043]

[0044] The degree of polymerization of the PEG is 60-400.

[0045] The above method adopts the asymmetric catalytic hydrogenation reduction method to prepare the solifenacin intermediate—(R)-(-)-3-quinine alcohol. In the catalyst structure, macromolecular structure polyethylene glycol (PEG) is introduced on the benzene ring of the nitrog...

Embodiment 1

[0071] This embodiment provides a preparation method of solifenacin intermediate [(R)-(-)-3-quinine alcohol], comprising the following steps:

[0072] Step 1: In a 5L autoclave, under an argon atmosphere, add 100g of 3-quinuclidinone hydrochloride from the feeding port, then add 1L of absolute ethanol to fully dissolve the raw materials, and cool down with cooling water Add 76 g of potassium tert-butoxide, stir well and continue to blow in argon gas for degassing by bubbling. The bubbling is continued for 1 hour, and the degassing is completed.

[0073] Step 2: Add 0.2 g of PEG having a structure shown in formula I through the feeding port, wherein the degree of polymerization of PEG is 180-220, and quickly close the feeding port. Replace the argon with hydrogen, slowly introduce hydrogen to 3.0Mpa, and close the inflation valve. Stir rapidly and set the temperature to 30 °C. When the pressure drops to remain constant, the reaction is considered to stop.

[0074]

[0075...

Embodiment 2

[0078] This embodiment provides a preparation method of Solifenacin intermediate [(R)-3-quinine alcohol], which is basically the same as Example 1, the difference is that the degree of polymerization of PEG in the catalyst is different, specifically comprising the following steps:

[0079] Step 1: In a 5L autoclave, under an argon atmosphere, add 100g of 3-quinuclidinone hydrochloride from the feeding port, then add 1L of absolute ethanol to fully dissolve the raw materials, and cool down with cooling water Add 76 g of potassium tert-butoxide, stir well and continue to blow in argon gas for degassing by bubbling. The bubbling is continued for 1 hour, and the degassing is completed.

[0080] Step 2: Add 0.2 g of PEG having a structure shown in formula I through the feeding port, wherein the degree of polymerization of PEG is 100-180, and quickly close the feeding port. Replace the argon with hydrogen, slowly introduce hydrogen to 3.0Mpa, and close the inflation valve. Stir rap...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
degree of polymerizationaaaaaaaaaa
degree of polymerizationaaaaaaaaaa
degree of polymerizationaaaaaaaaaa
Login to view more

Abstract

The present invention relates to a preparation method of a solifenacin intermediate. The preparation method includes the following steps: dissolving 3-quinuclidinone hydrochloride to obtain a 3-quinuclidinone hydrochloride solution; adding an alkaline compound and a catalyst to the 3-quinuclidinone hydrochloride solution , pass into hydrogen, stir and react to obtain reactant; filter and reclaim the catalyst in the reactant, the obtained filtrate is concentrated under reduced pressure and recrystallized; the catalyst has the structure shown in formula I; the degree of polymerization of the PEG is 60 ‑400. In the preparation method of the present invention, the catalyst separation is easy, the risk of heavy metal residues is reduced, the reaction operation is simple and safe, the three-waste treatment is simple and feasible, and it is environmentally friendly, and it is a green synthesis process. At the same time, the above method has high yield and Stable, low production cost, suitable for industrial production.

Description

technical field [0001] The invention relates to the technical field of drug synthesis, in particular to a preparation method of a solifenacin intermediate. Background technique [0002] Solifenacin, 1-(S)-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate-3-(R)quinuclidinate, is a selective toxin Alkaline M3 receptor antagonist, clinically used to treat overactive bladder with symptoms of urgency and frequent urination, and is a urinary system antispasmodic. (R)-(-)-3-quinine alcohol is an important intermediate in its synthesis. [0003] (R)-(-)-3-quinine alcohol, chemical name (R)-(-)-1-azabicyclo[2.2.2]octan-3-ol, its chemical structure is shown in the following formula: [0004] [0005] At present, the preparation methods of (R)-(-)-3-quinine alcohol mainly include chemical synthesis and biosynthesis. [0006] The biosynthesis method mainly uses microorganisms or enzymes to reduce 3-quinuclidinone to (R)-(-)-3-quinicol, or split quinuclidin-3-ol to obtain (R)-(-)...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07D453/02B01J31/24
CPCB01J31/2409B01J2231/643B01J2531/0258B01J2531/821C07B2200/07C07D453/02
Inventor 李彦雄蒙发明梁鹏程谢昌玖刘育培邹俊文
Owner ENANTIOTECH CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap